BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19874890)

  • 1. Effect of hydroxyl substitution of flavone on angiogenesis and free radical scavenging activities: a structure-activity relationship studies using computational tools.
    Rajesh G; Harshala S; Dhananjay G; Jadhav A; Vikram G
    Eur J Pharm Sci; 2010 Jan; 39(1-3):37-44. PubMed ID: 19874890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of selected flavonoids as antiangiogenic, anticancer, and radical scavenging agents: an experimental and in silico analysis.
    Gacche RN; Shegokar HD; Gond DS; Yang Z; Jadhav AD
    Cell Biochem Biophys; 2011 Dec; 61(3):651-63. PubMed ID: 21830125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavonoids as a scaffold for development of novel anti-angiogenic agents: An experimental and computational enquiry.
    Gacche RN; Meshram RJ; Shegokar HD; Gond DS; Kamble SS; Dhabadge VN; Utage BG; Patil KK; More RA
    Arch Biochem Biophys; 2015 Jul; 577-578():35-48. PubMed ID: 25937258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
    Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY
    Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tumor angiogenesis by TTF1 from extract of herbal medicine.
    Liu C; Li XW; Cui LM; Li LC; Chen LY; Zhang XW
    World J Gastroenterol; 2011 Nov; 17(44):4875-82. PubMed ID: 22171128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The flavonoid nobiletin inhibits tumor growth and angiogenesis of ovarian cancers via the Akt pathway.
    Chen J; Chen AY; Huang H; Ye X; Rollyson WD; Perry HE; Brown KC; Rojanasakul Y; Rankin GO; Dasgupta P; Chen YC
    Int J Oncol; 2015; 46(6):2629-38. PubMed ID: 25845666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key role of chemical hardness to compare 2,2-diphenyl-1-picrylhydrazyl radical scavenging power of flavone and flavonol O-glycoside and C-glycoside derivatives.
    Waki T; Nakanishi I; Matsumoto K; Kitajima J; Chikuma T; Kobayashi S
    Chem Pharm Bull (Tokyo); 2012; 60(1):37-44. PubMed ID: 22223373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiangiogenic activity of a soluble fragment of the VEGFR extracellular domain.
    Li H; Cao W; Chen Z; Acheampong DO; Jin H; Li D; Zhang J; Wang M
    Biomed Pharmacother; 2013 Sep; 67(7):599-606. PubMed ID: 23906761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tricin, 4',5,7-trihydroxy-3',5'-dimethoxyflavone, exhibits potent antiangiogenic activity in vitro.
    Han JM; Kwon HJ; Jung HJ
    Int J Oncol; 2016 Oct; 49(4):1497-504. PubMed ID: 27498749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel benzyl-substituted flavones as free radical (DPPH) scavengers and α-glucosidase inhibitors.
    Kumar GS; Tiwari AK; Rao VR; Prasad KR; Ali AZ; Babu KS
    J Asian Nat Prod Res; 2010 Nov; 12(11):978-84. PubMed ID: 21061220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periplasmic expression optimization of VEGFR2 D3 adopting response surface methodology: antiangiogenic activity study.
    Cao W; Li H; Zhang J; Li D; Acheampong DO; Chen Z; Wang M
    Protein Expr Purif; 2013 Aug; 90(2):55-66. PubMed ID: 23680780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemometric modeling of free radical scavenging activity of flavone derivatives.
    Mitra I; Saha A; Roy K
    Eur J Med Chem; 2010 Nov; 45(11):5071-9. PubMed ID: 20800321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavonoids inhibit hypoxia-induced vascular endothelial growth factor expression by a HIF-1 independent mechanism.
    Ansó E; Zuazo A; Irigoyen M; Urdaci MC; Rouzaut A; Martínez-Irujo JJ
    Biochem Pharmacol; 2010 Jun; 79(11):1600-9. PubMed ID: 20153296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.
    Nagaraju GP; Zhu S; Ko JE; Ashritha N; Kandimalla R; Snyder JP; Shoji M; El-Rayes BF
    Cancer Lett; 2015 Feb; 357(2):557-65. PubMed ID: 25497868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic activity of herboxidiene via downregulation of vascular endothelial growth factor receptor-2 and hypoxia-inducible factor-1α.
    Jung HJ; Kim Y; Shin JY; Sohng JK; Kwon HJ
    Arch Pharm Res; 2015 Sep; 38(9):1728-35. PubMed ID: 26195285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halogenated Flavonoid Derivatives Display Antiangiogenic Activity.
    Khater M; Watson KA; Boateng SY; Greco F; Osborn HMI
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35897938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between structures of hydroxyflavones and their antioxidative effects.
    Hyun J; Woo Y; Hwang DS; Jo G; Eom S; Lee Y; Park JC; Lim Y
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5510-3. PubMed ID: 20692831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis and characterization of protocatechuic acid derivants].
    Li QS; Wang W; Han QJ; Wang PL; Li Q; Lei HM
    Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(2):208-11. PubMed ID: 23672043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation.
    Li MH; Miao ZH; Tan WF; Yue JM; Zhang C; Lin LP; Zhang XW; Ding J
    Clin Cancer Res; 2004 Dec; 10(24):8266-74. PubMed ID: 15623602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.